You are here

Coronary Intervention & Surgery

 

Patients enrolled in a major clinical trial who underwent transfemoral transcatheter aortic valve replacement (TF-TAVR) in late 2011/early 2012 had significant declines in 1- and 2-year all-cause mortality compared with those who had the procedure performed earlier.

 

Recent Headlines

Abiomed’s quarterly revenue increases 38%

Led by strong sales of its Impella heart pump, Abiomed’s revenue for the fiscal third quarter of 2016 increased 38 percent to $85.8 million compared with the same time period in 2015.

Trial results show mortality rates following TAVR decreased over time

Patients enrolled in a major clinical trial who underwent transfemoral transcatheter aortic valve replacement (TF-TAVR) in late 2011/early 2012 had significant declines in 1- and 2-year all-cause mortality compared with those who had the procedure performed earlier.

Physician assistant intervention helps reduce readmissions and costs following cardiac surgery

Following up with patients at their homes soon after cardiac surgery and providing them with individualized care may help patients improve their health—and help hospitals save money at the same time.

Society of Thoracic Surgeons elects UPenn's Bavaria as President

The Society of Thoracic Surgeons (STS) elected Joseph E. Bavaria, MD, as president on Jan. 25 during its annual meeting in Phoenix, Ariz.

Study compares mechanical and bioprosthetic valves in middle-age adults

A database analysis of published studies found that adults between 40 and 70 years old had similar survival rates whether they received mechanical or stented bioprosthetic valves for aortic valve replacement. Although mechanical valves were associated with fewer reoperations, bioprosthetic valves were associated with fewer thromboembolic events and major bleeding events.

Perioperative statin use may improve outcomes following CABG

For patients undergoing CABG, perioperative statin therapy may lead to improvements in systematic inflammatory response and reductions in the risk of postoperative atrial fibrillation and perioperative mortality, according to a review of published literature. However, the use of statins was lower than the researchers expected.

FDA approves study evaluating the Sapien 3 valve in elderly patients with aortic stenosis

The FDA approved an investigational device exemption study evaluating the Sapien 3 valve in elderly patients with severe, symptomatic aortic stenosis who are at low risk for mortality.

SCAI releases expert consensus statement on cardiac catheterization of cancer patients

With more cancer patients being exposed to radiation and chemotherapy and potential cardiovascular complications, the Society for Cardiovascular Angiography and Interventions (SCAI) released an expert consensus statement on the cardiac catheterization of cancer patients.

FDA approves Perceval sutureless heart valve

The FDA approved the Perceval sutureless heart valve on Jan. 8. LivaNova PLC, the device’s manufacturer, announced the approval in a news release.

Assessing coronary stenting complications

For a long time, physicians and researchers have understood coronary stenting may lead to complications and future surgeries. A recent study suggests the risk may be higher than previously thought.

Pages